MAPT and Alzheimer disease: Because ageing-related processes are strongly implicated in promoting cognitive decline in Alzheimer’s disease and other tauopathies, we wondered if the facilitation of LTD by synaptotoxic tau-containing Alzheimer’s disease brain extracts was age-dependent.